Reaction
Retinal Scar reporting signals
As of the last recalculation, Retinal Scar appears in 457 FAERS reports alongside 9 co-occurring drug terms. The strongest observed disproportionality signal is RANIBIZUMAB (PRR 398.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ranibizumab | 154 | 398.0 | 400.3 |
| Aflibercept | 48 | 78.2 | 78.3 |
| Ganciclovir Sodium | 14 | 62.1 | 62.2 |
| Ganciclovir | 12 | 54.8 | 54.9 |
| Thiotepa | 11 | 53.7 | 53.8 |
| Sirolimus | 15 | 52.4 | 52.5 |
| Valganciclovir Hydrochloride Powder, | 13 | 49.9 | 50.0 |
| Valganciclovir | 15 | 37.4 | 37.5 |
| Valganciclovir Hydrochloride | 15 | 37.4 | 37.5 |